Evidence for succinate production by reduction of fumarate during hypoxia in isolated adult rat heart cells.
It has been demonstrated that perfusion of myocardium with glutamic acid or tricarboxylic acid cycle intermediates during hypoxia or ischemia, improves cardiac function, increases ATP levels, and stimulates succinate production. In this study isolated adult rat heart cells were used to investigate the mechanism of anaerobic succinate formation and examine beneficial effects attributed to ATP generated by this pathway. Myocytes incubated for 60 min under hypoxic conditions showed a slight loss of ATP from an initial value of 21 +/- 1 nmol/mg protein, a decline of CP from 42 to 17 nmol/mg protein and a fourfold increase in lactic acid production to 1.8 +/- 0.2 mumol/mg protein/h. These metabolite contents were not altered by the addition of malate and 2-oxoglutarate to the incubation medium nor were differences in cell viability observed; however, succinate release was substantially accelerated to 241 +/- 53 nmol/mg protein. Incubation of cells with [U-14C]malate or [2-U-14C]oxoglutarate indicates that succinate is formed directly from malate but not from 2-oxoglutarate. Moreover, anaerobic succinate formation was rotenone sensitive. We conclude that malate reduction to succinate occurs via the reverse action of succinate dehydrogenase in a coupled reaction where NADH is oxidized (and FAD reduced) and ADP is phosphorylated. Furthermore, by transaminating with aspartate to produce oxaloacetate, 2-oxoglutarate stimulates cytosolic malic dehydrogenase activity, whereby malate is formed and NADH is oxidized. In the form of malate, reducing equivalents and substrate are transported into the mitochondria where they are utilized for succinate synthesis.
Hohl
C
C
Department of Biochemistry, Universität Düsseldorf, Federal Republic of Germany.
Oestreich
R
R
Rösen
P
P
Wiesner
R
R
Grieshaber
M
M
D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D002470:Cell Survival; D002851:Chromatography, High Pressure Liquid; D003847:Deoxyglucose / Q000494:pharmacology; D005650:Fumarates / Q000378:metabolism*; D000860:Hypoxia / Q000378:metabolism*; D007656:Ketoglutaric Acids / Q000378:metabolism; D008293:Malates / Q000378:metabolism; D009206:Myocardium / Q000378:metabolism*; D010725:Phosphocreatine / Q000378:metabolism; D051381:Rats; D013386:Succinates / Q000096:biosynthesis*; D019802:Succinic Acid
D005650:Fumarates; D007656:Ketoglutaric Acids; D008293:Malates; D013386:Succinates; D010725:Phosphocreatine; C030298:malic acid; C032005:fumaric acid; D000255:Adenosine Triphosphate; D003847:Deoxyglucose; D019802:Succinic Acid